ABOUTTEAMPORTFOLIOCONTACT

*+Acura Pharmaceuticals

Anacor Pharmaceuticals

*+Anadys Pharmaceuticals

Archemix

Cardiokine

+Cervelo Pharmaceuticals

CoLucid Pharmaceuticals

Cyrenaic Pharmaceuticals

*D-Pharm

*+Dynavax

Edusa Pharmaceuticals

Elevation Pharmaceuticals

Epigenesis Pharmaceuticals

Inotek Pharmaceuticals

Janus Therapeutics

Medical Present Value

MicroCHIPS

*+Minster Pharmaceuticals

NephroGenex

*+NitroMed

Orqis Medical

PHT Corporation

*+Renovo

Resolvyx Pharmaceuticals

Sentinella Pharmaceuticals

Somnus Therapeutics

Sonkei Pharmaceuticals

*+Tercica Pharmaceuticals

*+Vanda Pharmaceuticals

Vaxart


NitroMed is commercializing a proprietary product for the treatment of congestive heart failure in African-American patients based on the therapeutic benefits of nitric oxide.

* public company
+ partial or full exit

© Care Capital, LLC :: All Rights Reserved